Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nobuhisa Ueda

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
Human Psychopharmacology|October 28, 2011
Three polymorphisms of the eNOS gene and plasma levels of metabolites of nitric oxide in depressed Japanese patients: a preliminary reportAtsuko Ikenouchi-Sugita, Reiji Yoshimura, Taro Kishi, et al.
Frontiers in Psychiatry|March 22, 2021
Association Between Serum Insulin-Like Growth Factor 1 Levels and the Clinical Symptoms of Chronic Schizophrenia: Preliminary FindingsNaomichi Okamoto, Koji Yoshino, Shogo Kitagawa, et al.
Human Psychopharmacology|August 21, 2010
No difference in adherence to paroxetine between depressed patients with early remission and those with late remission based on monitoring of plasma paroxetine concentrationsReiji Yoshimura, Wakako Umene-Nakano, Nobuhisa Ueda, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|January 30, 2010
Serum brain-derived neurotrophic factor levels as a novel biological marker for the activities of psychiatric symptoms in systemic lupus erythematosusAtsuko Ikenouchi-Sugita, Reiji Yoshimura, Tatsuya Okamoto, et al.
Psychiatry Research|September 14, 2010
Relationships between stress, social adaptation, personality traits, brain-derived neurotrophic factor and 3-methoxy-4-hydroxyphenylglycol plasma concentrations in employees at a publishing company in JapanKanae Okuno, Reiji Yoshimura, Nobuhisa Ueda, et al.
Plos One|December 14, 2011
Pharmacogenetic & pharmacokinetic biomarker for efavirenz based ARV and rifampicin based anti-TB drug induced liver injury in TB-HIV infected patientsGetnet Yimer, Nobuhisa Ueda, Abiy Habtewold, et al.
Human Psychopharmacology|April 15, 2005
An open study of risperidone liquid in the acute phase of schizophreniaReiji Yoshimura, Jun Nakamura, Koji Shinkai, et al.
Psychiatry Research|March 16, 2010
Critical examination of a correlation between brain gamma-aminobutyric acid (GABA) concentrations and a personality trait of extroversion in healthy volunteers as measured by a 3 Tesla proton magnetic resonance spectroscopy studyNaoki Goto, Reiji Yoshimura, Junji Moriya, et al.
Human Psychopharmacology|December 1, 2009
Associations between plasma levels of 3-methoxy-4-hydroxyphenylglycol (MHPG) and negative symptoms or cognitive impairments in early-stage schizophreniaNaoki Goto, Reiji Yoshimura, Shingo Kakeda, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 27, 2007
Treatment with risperidone for 4 weeks increased plasma 3-methoxy-4-hydroxypnenylglycol (MHPG) levels, but did not alter plasma brain-derived neurotrophic factor (BDNF) levels in schizophrenic patientsReiji Yoshimura, Hikaru Hori, Atsuko Sugita, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Human Psychopharmacology|October 28, 2011
Three polymorphisms of the eNOS gene and plasma levels of metabolites of nitric oxide in depressed Japanese patients: a preliminary reportAtsuko Ikenouchi-Sugita, Reiji Yoshimura, Taro Kishi, et al.
Frontiers in Psychiatry|March 22, 2021
Association Between Serum Insulin-Like Growth Factor 1 Levels and the Clinical Symptoms of Chronic Schizophrenia: Preliminary FindingsNaomichi Okamoto, Koji Yoshino, Shogo Kitagawa, et al.
Human Psychopharmacology|August 21, 2010
No difference in adherence to paroxetine between depressed patients with early remission and those with late remission based on monitoring of plasma paroxetine concentrationsReiji Yoshimura, Wakako Umene-Nakano, Nobuhisa Ueda, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|January 30, 2010
Serum brain-derived neurotrophic factor levels as a novel biological marker for the activities of psychiatric symptoms in systemic lupus erythematosusAtsuko Ikenouchi-Sugita, Reiji Yoshimura, Tatsuya Okamoto, et al.
Psychiatry Research|September 14, 2010
Relationships between stress, social adaptation, personality traits, brain-derived neurotrophic factor and 3-methoxy-4-hydroxyphenylglycol plasma concentrations in employees at a publishing company in JapanKanae Okuno, Reiji Yoshimura, Nobuhisa Ueda, et al.
Plos One|December 14, 2011
Pharmacogenetic & pharmacokinetic biomarker for efavirenz based ARV and rifampicin based anti-TB drug induced liver injury in TB-HIV infected patientsGetnet Yimer, Nobuhisa Ueda, Abiy Habtewold, et al.
Human Psychopharmacology|April 15, 2005
An open study of risperidone liquid in the acute phase of schizophreniaReiji Yoshimura, Jun Nakamura, Koji Shinkai, et al.
Psychiatry Research|March 16, 2010
Critical examination of a correlation between brain gamma-aminobutyric acid (GABA) concentrations and a personality trait of extroversion in healthy volunteers as measured by a 3 Tesla proton magnetic resonance spectroscopy studyNaoki Goto, Reiji Yoshimura, Junji Moriya, et al.
Human Psychopharmacology|December 1, 2009
Associations between plasma levels of 3-methoxy-4-hydroxyphenylglycol (MHPG) and negative symptoms or cognitive impairments in early-stage schizophreniaNaoki Goto, Reiji Yoshimura, Shingo Kakeda, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 27, 2007
Treatment with risperidone for 4 weeks increased plasma 3-methoxy-4-hydroxypnenylglycol (MHPG) levels, but did not alter plasma brain-derived neurotrophic factor (BDNF) levels in schizophrenic patientsReiji Yoshimura, Hikaru Hori, Atsuko Sugita, et al.
Pageof 8